HOTH
Income statement / Annual
Last year (2025), Hoth Therapeutics Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Hoth Therapeutics Inc's net income was -$12.47 M.
See Hoth Therapeutics Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$31.62 K
|
$28.25 K
|
$188.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$31.62 K
|
-$28.25 K
|
-$188.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$5.95 M
|
$3.25 M
|
$3.48 M
|
$4.93 M
|
$7.53 M
|
$2.89 M
|
$2.12 M
|
$1.02 M
|
$586.84 K
|
| General & Administrative Expenses |
$6.41 M
|
$4.97 M
|
$4.21 M
|
$6.13 M
|
$6.57 M
|
$2.93 M
|
$5.06 M
|
$1.22 M
|
$320.12 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.48 M
|
$0.00
|
$0.00
|
$964.33 K
|
| Selling, General & Administrative Expenses |
$6.41 M
|
$4.97 M
|
$4.21 M
|
$6.13 M
|
$6.57 M
|
$4.41 M
|
$5.06 M
|
$1.22 M
|
$1.28 M
|
| Other Expenses |
-$1.25 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$538.58 K
|
$258.71 K
|
$0.00
|
| Operating Expenses |
$11.11 M
|
$8.22 M
|
$7.69 M
|
$11.07 M
|
$14.10 M
|
$7.30 M
|
$7.71 M
|
$2.50 M
|
$1.87 M
|
| Cost And Expenses |
$11.11 M
|
$8.22 M
|
$7.69 M
|
$11.07 M
|
$14.10 M
|
$7.30 M
|
$7.71 M
|
$2.50 M
|
$1.87 M
|
| Interest Income |
$680.00
|
$27.71 K
|
$51.77 K
|
$6.37 K
|
$0.00
|
$8.00
|
$25.00
|
$0.00
|
$216.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$305.41 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$8.22 M
|
$7.69 M
|
$11.07 M
|
$0.00
|
$1.04 K
|
$1.23 K
|
$1.22 K
|
$188.00
|
| EBITDA |
-$11.11 M |
$27.13 K |
-$153.15 K |
$0.00 |
-$14.10 M |
-$7.30 M |
-$7.71 M |
-$2.49 M |
-$2.02 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$1.36 M
|
$27.13 K
|
-$153.15 K
|
-$306.40 K
|
-$212.27 K
|
$104.16 K
|
$10.36 K
|
$0.00
|
-$144.00 K
|
| Income Before Tax |
-$12.47 M
|
-$8.19 M
|
-$7.85 M
|
-$11.37 M
|
-$14.31 M
|
-$7.20 M
|
-$7.70 M
|
-$2.50 M
|
-$2.02 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2.00
|
| Net Income |
-$12.47 M
|
-$8.19 M
|
-$7.85 M
|
-$11.37 M
|
-$14.31 M
|
-$7.20 M
|
-$7.69 M
|
-$2.50 M
|
-$2.02 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.9 |
-1.28 |
-2.3 |
-9.5 |
-16.03 |
-14.56 |
-20.99 |
-6.62 |
-5.24 |
| EPS Diluted |
-0.9 |
-1.28 |
-2.3 |
-9.5 |
-16.03 |
-14.56 |
-20.99 |
-6.62 |
-5.24 |
| Weighted Average Shares Out |
$13.81 M
|
$6.38 M
|
$3.41 M
|
$1.20 M
|
$893.20 K
|
$494.51 K
|
$366.58 K
|
$376.98 K
|
$384.48 K
|
| Weighted Average Shares Out Diluted |
$13.81 M
|
$6.38 M
|
$3.41 M
|
$1.20 M
|
$893.20 K
|
$494.51 K
|
$366.58 K
|
$376.98 K
|
$384.48 K
|
| Link |
|
|
|
|
|
|
|
|
|
